Table 1.
Participant characteristics (n=228)
| Characteristic | Mean (SD) or % | Range | Skewness | Kurtosis |
|---|---|---|---|---|
| Socio-demographic | ||||
| Age | 51.0 (13.3) | 21.0- 82.0 | -0.1 | -0.7 |
| Male | 30.3% | - | - | - |
| White | 91.3% | - | - | - |
| Education (in years) | 15.6 (2.8) | 4.0-22.0 | -0.2 | 1.7 |
| Clinical | ||||
| Self-reported vasculitis type | ||||
| ANCA-associated granulomatous | 59.2% | |||
| Churg Strauss Syndrome | 12.7% | |||
| Microscopic Polyangiitis | 7.9% | - | - | - |
| Takayasu Arteritis | 4.8% | |||
| Other | 15.4% | |||
| Years with disease | 6.4 (6.2) | 0.5-36.5 | -2.0 | 5.2 |
| Currently experiencing flare/relapse | 28.4% | - | - | - |
| Have health insurance | 93.4% | - | - | - |
| Other | ||||
| Medication non-adherence† | 1.7 (0.7) | 1.0-4.4 | 1.2 | 1.6 |
| Adherence self-efficacy‡ | 4.0 (0.9) | 1.0-5.0 | -0.6 | -0.4 |
| Outcome expectations* | 4.4 (0.6) | 2.2-5.0 | -1.3 | 1.6 |
| Conflicting information** | 1.6 (1.8) | 0.0-6.0 | 0.8 | -0.4 |
| Physician support*** | 3.1 (0.7) | 2.0-4.0 | 0.1 | -0.8 |
†
Response options ranged from 1 to 5; higher scores reflect greater non-adherence
‡
Response options range from 1= ‘not at all confident’ to 5= ‘very confident’
*
Response options range from 1= ‘strongly disagree’ to 5= ‘strongly agree’
**
Higher scores reflect greater amounts of conflicting information
***
Response options range from 1= ‘does not do this’ to 4= ‘does this a lot’